Paper41540690
[Shihu Mixture alleviates diabetic cardiomyopathy in rats by Sirt3-mediated upregulation of myocardial mitochondrial mitophagy pathway].
Lin X and 4 others. Nan Fang Yi Ke Da Xue Xue Bao, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. [Shihu Mixture alleviates diabetic cardiomyopathy in rats by Sirt3-mediated upregulation of myocardial mitochondrial mitophagy pathway]. Papers, record 41540690. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41540690
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- [Shihu Mixture alleviates diabetic cardiomyopathy in rats by Sirt3-mediated upregulation of myocardial mitochondrial mitophagy pathway].
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetic Cardiomyopathies | Major topic |
| Mitophagy | Major topic |
| Mitochondria, Heart | Major topic |
| Drugs, Chinese Herbal | Major topic |
| Sirtuin 3 | Major topic |
| Animals | |
| Male | |
| Rats | |
| Rats, Sprague-Dawley | |
| Diabetes Mellitus, Experimental | |
| Myocardium | |
| Up-Regulation | |
| Tumor Necrosis Factor-alpha | |
| Sirtuins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 81973827 | National Natural Science Foundation of China | PubMed |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36295866 | Effects of Rice-Husk Silica Liquid in Streptozotocin-Induced Diabetic Mice. | Metabolites | 2022 | https://conductscience.org/library/papers/36295866 | PubMed |
| 2 | 40052435 | Therapeutic Targeting of Decr1 Ameliorates Cardiomyopathy by Suppressing Mitochondrial Fatty Acid Oxidation in Diabetic Mice. | J Cachexia Sarcopenia Muscle | 2025 | https://conductscience.org/library/papers/40052435 | PubMed |
| 3 | 30646747 | Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase α2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo. | Circulation | 2019 | https://conductscience.org/library/papers/30646747 | PubMed |
| 4 | 34646830 | Mitophagy in Diabetic Cardiomyopathy: Roles and Mechanisms. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34646830 | PubMed |
| 5 | 32080423 | Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. | Nat Rev Cardiol | 2020 | https://conductscience.org/library/papers/32080423 | PubMed |
| 6 | 36147470 | Mitochondrial quality control in diabetic cardiomyopathy: from molecular mechanisms to therapeutic strategies. | Int J Biol Sci | 2022 | https://conductscience.org/library/papers/36147470 | PubMed |
| 7 | 29348027 | Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy. | J Am Coll Cardiol | 2018 | https://conductscience.org/library/papers/29348027 | PubMed |
| 8 | 34506248 | The protective effects of S14G-humanin (HNG) against streptozotocin (STZ)-induced cardiac dysfunction. | Bioengineered | 2021 | https://conductscience.org/library/papers/34506248 | PubMed |
| 9 | 32961025 | Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/32961025 | PubMed |
| 10 | 36742465 | The dynamic interplay between cardiac mitochondrial health and myocardial structural remodeling in metabolic heart disease, aging, and heart failure. | J Cardiovasc Aging | 2023 | https://conductscience.org/library/papers/36742465 | PubMed |
| 11 | 30414140 | Introduction to FOXO Biology. | Methods Mol Biol | 2019 | https://conductscience.org/library/papers/30414140 | PubMed |
| 12 | 35904170 | The metabolic and molecular mechanisms of α‑mangostin in cardiometabolic disorders (Review). | Int J Mol Med | 2022 | https://conductscience.org/library/papers/35904170 | PubMed |
| 13 | 34720029 | Newcastle disease virus degrades SIRT3 via PINK1-PRKN-dependent mitophagy to reprogram energy metabolism in infected cells. | Autophagy | 2022 | https://conductscience.org/library/papers/34720029 | PubMed |
| 14 | 35784531 | Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35784531 | PubMed |
| 15 | 23652584 | Assessment of cardiac inflammation and remodeling during the development of streptozotocin-induced diabetic cardiomyopathy in vivo: a time course analysis. | Int J Mol Med | 2013 | https://conductscience.org/library/papers/23652584 | PubMed |
| 16 | 35240195 | Effect of Sirt3 on retinal pigment epithelial cells in high glucose through Foxo3a/ PINK1-Parkin pathway mediated mitophagy. | Exp Eye Res | 2022 | https://conductscience.org/library/papers/35240195 | PubMed |
| 17 | 36407069 | Mitochondrial Quality Control Mechanisms during Diabetic Cardiomyopathy. | JMA J | 2022 | https://conductscience.org/library/papers/36407069 | PubMed |
| 18 | 37820568 | Targeting mitochondrial quality control for diabetic cardiomyopathy: Therapeutic potential of hypoglycemic drugs. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/37820568 | PubMed |
| 19 | 39022683 | The interregulatory circuit between non-coding RNA and apoptotic signaling in diabetic cardiomyopathy. | Noncoding RNA Res | 2024 | https://conductscience.org/library/papers/39022683 | PubMed |
| 20 | 33639953 | MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics. | Cardiovasc Diabetol | 2021 | https://conductscience.org/library/papers/33639953 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42871652 | The core mechanism of traditional Chinese medicine in improving myocardial fibrosis: restoring the dynamic balance of mitochondrial quality control. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42871652 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41540690
GET https://conductscience.org/api/papers/v1/41540690/references?page=2